阿片类药物不良反应:国家药物警戒数据库研究
最常见不良反应为恶心、头晕和呕吐,女性报告更多;曲马多相关呕吐的ROR女性/男性=2.17,女性显著更高。芬太尼涉及最多滥用、误用和用药错误报告,阿片类药物在这些方面的报告比例高于其他药物。
要点
- 阿片类最常见不良反应为恶心、头晕和呕吐,且女性报告更频繁。
- 曲马多相关呕吐在女性中报告比例显著更高(ROR女性/男性=2.17)。
- 芬太尼涉及最多滥用、误用和用药错误相关报告。
核心结论
- 使用阿片类药物的患者主要经历恶心、头晕和呕吐等不良反应。
- 除曲马多相关呕吐外,阿片类药物不良反应报告未见显著性别差异。
- 阿片类药物在滥用、误用和用药错误方面的报告比例高于其他药物。
研究设计与样本
- 基于荷兰Lareb药物警戒中心自发报告系统的描述性研究。
- 共纳入8769份报告,计算并按性别和药物支出校正报告比值比(ROR)。
主要发现
- 曲马多报告数最多(n=2746),羟考酮或曲马多在研究期间每年报告数最高。
- 最常见不良反应为恶心,其次为头晕和呕吐,独立于性别,且女性报告更频繁。
- 曲马多相关呕吐的ROR女性/男性=2.17,女性显著更高。
- 按支出校正后,丁丙诺啡不良反应报告最多,应用部位超敏反应、应用部位反应和皮疹的ROR较高。
- 芬太尼涉及最多滥用、误用和用药错误相关不良反应报告。
临床怎么用
- 临床应监测阿片类药物常见不良反应如恶心、头晕和呕吐,关注女性患者呕吐风险。
- 对芬太尼应警惕滥用、误用和用药错误风险。
- 丁丙诺啡应用部位相关不良反应报告较多,使用时需关注局部反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Opioids are commonly used as analgesics; however, like any medicine, they can produce adverse drug reactions (ADRs), including nausea, constipation, dependence, and respiratory depression, that result in harmful and fatal events. Therefore, it is essential to monitor the safety of these drugs in clinical practice. OBJECTIVE: This study aimed to characterize the safety profile of opioids by conducting a descriptive study based on a spontaneous reporting system (SRS) for ADRs in The Netherlands, focusing on abuse, misuse, medication errors, and differences between sexes. METHODS: Reports submitted to the Netherlands Pharmacovigilance Centre Lareb from January 2003 to December 2021 with an opioid drug as the suspected/interacting medicine were analyzed. Reporting odds ratios (RORs) for drug-ADR combinations were calculated, analyzed, and corrected for sex and drug utilization (expenditure) for the Dutch population. RESULTS: A total of 8769 reports were analyzed. Tramadol was the opioid with the most reports during the period (n = 2746), while oxycodone or tramadol had the highest number of reports per year in the study period. The most reported ADRs from opioid use were nausea, followed by dizziness and vomiting, independent of sex, and all of them were more often reported in women. Vomiting associated with tramadol (ROR females/males = 2.17) was significantly higher in women. Buprenorphine was responsible for most ADRs when corrected for expenditure, with high RORs observed with application site hypersensitivity, application site reaction, and application site rash. Fentanyl gave rise to most of the reports of ADRs concerning abuse, misuse, and medication errors. CONCLUSION: Patients treated with opioids experienced ADRs, primarily nausea, dizziness, and vomiting. For those groups of drugs, no significant differences were found between the sexes, except for the vomiting associated with tramadol. In general, ADRs related to opioids presented higher RORs when uncorrected and corrected for sexes and expenditure than other drugs. There was more disproportionate reporting for ADRs concerning abuse, misuse, and medication errors for opioids than other drugs in the Dutch SRS.
引用
- Gustafsson M, Matos C, Joaquim J, et al. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database. Drug Saf. 2023. PMID: 37824028. doi:10.1007/s40264-023-01351-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。